Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial-Reference-Cited by-同舟云学术

Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial

Published:2021-11 Issue:11 Volume:20 Page:895-906
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Kehoe Patrick Gavin,Turner Nicholas,Howden Beth,Jarutyte Lina,Clegg Shona Louise,Malone Ian Brian,Barnes Josephine,Nielsen Casper,Sudre Carole Hélène,Wilson Aileen,Thai Ngoc Jade,Blair Peter Sinclair,Coulthard Elizabeth,Lane Janet Athene,Passmore Peter,Taylor Jodi,Mutsaerts Henk-Jan,Thomas David Lee,Fox Nick Charles,Wilkinson Ian,Ben-Shlomo Yoav,Harkness Kirsty,Kuruvilla Tarun,McShane Rupert,Connelly Peter,Duncan Gordon,Calvert Lucy,Lawrie Alasdair,Sheridan Matthew,Jackson Eric,Udeze Bernard,Pearson Stephen,Langheinrich Tobias,Wagle Suvarna,Butchart Joseph,Macharouthu Ajay,Donaldson Andrew,Neil Wendy,Pattan Vivek,Findlay David,Thomas Alan,Barber Robert,Byrne Andrew,Dalvi Madhusudan,Negi Rashi,McGuinness Bernadette

Funder

Medical Research Council

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference30 articles.

1. Clinical trials for disease-modifying therapies in Alzheimer's disease: a primer, lessons learned, and a blueprint for the future;Cummings;J Alzheimers Dis,2018

2. Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials;Yu;J Neurol Neurosurg Psychiatry,2020

3. Alzheimer's disease neuroimaging I. Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis;Iturria-Medina;Nat Commun,2016

4. Cerebrovascular alterations in Alzheimer disease;Iadecola;Circ Res,2018

5. Evaluation of amyloid protective factors and Alzheimer disease neurodegeneration protective factors in elderly individuals;Vemuri;JAMA Neurol,2017

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subclinical structural atypicality of retinal thickness and its association with gray matter volume in the visual cortex of maltreated children;Scientific Reports;2024-05-20

2. Downregulation of miR-181c-5p in Alzheimer’s disease weakens the response of microglia to Aβ phagocytosis;Scientific Reports;2024-05-20

3. Tetrazole derivatives in the management of neurological disorders: Recent advances on synthesis and pharmacological aspects;European Journal of Medicinal Chemistry;2024-05

4. A Review of Recent Advances in the Management of Alzheimer’s Disease;Cureus;2024-04-16

5. Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer’s disease with real-world clinical validation;npj Digital Medicine;2024-02-26